Ausgabe 3/2010
Inhalt (7 Artikel)
A case of suicide attempt with long-acting methylphenidate (Concerta)
Esra Ozdemir, Mehmet Goksin Karaman, Nihal Yurteri, Ayten Erdogan
Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study
Javier Quintero, Francisco López-Muñoz, Cecilio Alamo, Mercedes Loro, Natalia García-Campos
Methylphenidate and if-then plans are comparable in modulating the P300 and increasing response inhibition in children with ADHD
I. Paul-Jordanov, M. Bechtold, C. Gawrilow
Prevalence of attention deficit hyperactivity disorder in schoolchildren in Athens, Greece. Association of ADHD subtypes with social and academic impairment
M. Skounti, S. Giannoukas, E. Dimitriou, S. Nikolopoulou, E. Linardakis, A. Philalithis
A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin® LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeks
Eberhard Schulz, Christian Fleischhaker, Klaus Hennighausen, Philip Heiser, Frank Haessler, Martin Linder, Kirsten Stollhoff, Andreas Warnke, Monika Baier, Jan Klatt
Toward a better understanding of ADHD: LPHN3 gene variants and the susceptibility to develop ADHD
Mauricio Arcos-Burgos, Maximilian Muenke
Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder
Reza Rastmanesh